Stratified analysis based on BM tumor burden (13% as the cutoff) showed that there were no significant differences in CR/CRi rates between patients who used G-CSF and those did not in both low- and high-BM tumor burden groups (Table 3). Here, CSF3 is linked to neoplasm.